ORIENTBIO Inc. | Income Statement
Fiscal year is April-March. All values KRW Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
83,722
93,709
105,050
109,019
121,208
30,373
Cost of Goods Sold (COGS) incl. D&A
71,545
78,179
89,841
101,408
106,629
28,012
Gross Income
12,178
15,530
15,209
7,611
14,579
2,361
SG&A Expense
15,085
14,778
12,734
17,112
20,694
11,181
EBIT
3,384
548
2,267
-
6,704
9,791
Unusual Expense
4,166
-
2,008
8,478
3,796
1,362
Non Operating Income/Expense
136
405
15
379
1,072
1,223
Interest Expense
3,687
3,397
3,276
2,832
5,107
3,441
Pretax Income
10,234
1,820
2,631
23,228
16,211
13,182
Income Tax
17
34
115
2,069
-
-
Consolidated Net Income
10,218
1,786
2,516
25,297
16,211
13,182
Net Income
9,551
1,749
3,009
19,582
13,865
12,041
Net Income After Extraordinaries
9,551
1,749
3,009
19,582
13,865
4,576
Net Income Available to Common
9,551
1,749
3,009
19,582
13,865
19,506
EPS (Basic)
91.38
15.23
21.00
124.00
85.00
111.52
Basic Shares Outstanding
104
112
142
158
163
175
EPS (Diluted)
91.85
15.63
21.23
124.01
85.24
111.52
Diluted Shares Outstanding
104
112
142
158
163
175
EBITDA
893
6,779
7,775
5,148
592
1,714
Other Operating Expense
477
204
208
2,311
589
971
Non-Operating Interest Income
868
623
335
275
469
189
Minority Interest Expense
667
37
493
5,714
2,346
1,141
About ORIENTBIO
View Profile
